Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/04/2024
UPDATED: 11/04/2024
DUE: 10/20/2027
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological ac...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/04/2019
UPDATED: 10/12/2021
DUE: 10/12/2121
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Co...
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/01/2023
UPDATED: 11/13/2023
DUE: 08/18/2026
Reissue of PAR-18-541. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projec...
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
$300,000
HHS-NIH11
POSTED: 11/01/2024
UPDATED: 11/01/2024
DUE: 10/16/2026
This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. ...
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 05/26/2023
UPDATED: 05/26/2023
DUE: 07/08/2026
The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifica...
Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
HHS-NIH11
POSTED: 05/26/2023
UPDATED: 09/09/2025
DUE: 09/25/2026
This funding opportunity announcement (FOA) encourages grant applications that support the activities of the National Primate Research Centers (NPRCs). Nonhuman primates (NHPs) are most closely relate...
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
HHS-NIH11
POSTED: 05/26/2023
UPDATED: 05/26/2023
DUE: 05/25/2026
The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safet...
NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required)
HHS-NIH11
POSTED: 05/26/2023
UPDATED: 05/26/2023
DUE: 05/25/2026
The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safet...
NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required)
HHS-NIH11
POSTED: 05/25/2023
UPDATED: 05/25/2023
DUE: 05/25/2026
The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safet...
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 05/19/2023
UPDATED: 05/19/2023
DUE: 04/03/2026
The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing both non-hormonal contraceptive and reproductive health related product development. This facility has the c...